ASXL1 and Buschke-Ollendorff syndrome: TCF7, which is transcriptionally upregulated in BOS samples, is an important regulator of self-renewal and differentiation in multipotential hematopoietic cell lines (74), which could offer insight into the pathogenesis of myeloid cancers with truncating ASXL1 mutations.